Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?, Journal of Clinical Oncology, vol.22, issue.10, pp.1797-1806, 2004. ,
DOI : 10.1200/JCO.2004.09.059
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, Lancet, vol.370, pp.2020-2029, 2007. ,
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2343-2351, 2004. ,
DOI : 10.1056/NEJMoa032709
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol, vol.22, pp.3408-3419, 2004. ,
ESMO Guidelines Working Group. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, issue.6, pp.64-72, 2013. ,
Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data, European Journal of Cancer, vol.46, issue.15, pp.2788-2798, 2010. ,
DOI : 10.1016/j.ejca.2010.05.009
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer, Journal of Clinical Oncology, vol.28, issue.20, pp.3219-3226, 2010. ,
DOI : 10.1200/JCO.2009.27.1825
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin, Annals of Oncology, vol.21, issue.4, pp.772-780, 2010. ,
DOI : 10.1093/annonc/mdp383
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study, Journal of the National Cancer Institute, vol.108, issue.7, p.438, 2016. ,
DOI : 10.1093/jnci/djv438
Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR, Gastroenterology, vol.123, issue.6, pp.1804-1811, 2002. ,
DOI : 10.1053/gast.2002.37070
Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy, Diseases of the Colon & Rectum, vol.51, issue.5, pp.503-507, 2008. ,
DOI : 10.1007/s10350-008-9246-z
Population-based study of prognostic factors in stage II colonic cancer, British Journal of Surgery, vol.24, issue.7, pp.866-871, 2006. ,
DOI : 10.1002/bjs.5345
Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence, Diseases of the Colon & Rectum, vol.44, issue.11, pp.1682-1688, 2001. ,
DOI : 10.1007/BF02234390
Number of Lymph Nodes Retrieved is an Important Determinant of Survival of Patients with Stage II and Stage III Colorectal Cancer, Japanese Journal of Clinical Oncology, vol.42, issue.1, pp.29-35, 2012. ,
DOI : 10.1093/jjco/hyr164
The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes Examined, Annals of Surgical Oncology, vol.122, issue.1, pp.65-71, 2003. ,
DOI : 10.1245/ASO.2003.03.058
Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089, Journal of Clinical Oncology, vol.21, issue.15, pp.2912-2919, 2003. ,
DOI : 10.1200/JCO.2003.05.062
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, New England Journal of Medicine, vol.353, issue.25, pp.2654-2666, 2005. ,
DOI : 10.1056/NEJMoa051424
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006. ,
DOI : 10.1126/science.1129139
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009. ,
DOI : 10.1200/JCO.2008.19.6147
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial, Annals of Oncology, vol.26, issue.1, pp.126-132, 2015. ,
DOI : 10.1093/annonc/mdu499
Lymph Node Harvest in Colon Cancer: Influence of Microsatellite Instability and Proximal Tumor Location, World Journal of Surgery, vol.208, issue.12, pp.2695-2703, 2009. ,
DOI : 10.1007/s00268-009-0255-4
Prognostic factors of overall survival for patients with stage II colon cancer, Acta Medica Academica, vol.43, issue.2, pp.134-143, 2014. ,
DOI : 10.5644/ama2006-124.112
High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer, Annals of Surgical Oncology, vol.53, issue.4, pp.1222-1230, 2012. ,
DOI : 10.1245/s10434-011-2091-7
Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer, International Surgery, vol.98, issue.2, pp.114-121, 2013. ,
DOI : 10.9738/CC131
Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy, European Journal of Cancer, vol.45, issue.17, pp.2992-2999, 2009. ,
DOI : 10.1016/j.ejca.2009.07.008
Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.31, pp.5131-5137, 2009. ,
DOI : 10.1200/JCO.2009.22.4949
Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue, Journal of Clinical Oncology, vol.29, issue.35, pp.4620-4626, 2011. ,
DOI : 10.1200/JCO.2011.35.4498
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581, Journal of Clinical Oncology, vol.31, issue.14, pp.1775-1781, 2013. ,
DOI : 10.1200/JCO.2012.45.1096
Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer, British Journal of Cancer, vol.785, issue.8, pp.2081-2089, 2014. ,
DOI : 10.1038/bjc.2011.504
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series, Annals of Oncology, vol.24, issue.5, pp.1274-1282, 2013. ,
DOI : 10.1093/annonc/mds614
Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?, Annals of Coloproctology, vol.30, issue.1, pp.28-34, 2014. ,
DOI : 10.3393/ac.2014.30.1.28
Prognostic and predictive significance of MSI in stages II/III colon cancer, World Journal of Gastroenterology, vol.20, issue.22, pp.6809-6814, 2014. ,
DOI : 10.3748/wjg.v20.i22.6809
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Annals of Oncology, vol.25, issue.12, pp.2378-2385, 2014. ,
DOI : 10.1093/annonc/mdu464
Prognostic Effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post hoc analysis of the PETACC-8 trial, JAMA Oncol, vol.14, pp.1-11, 2016. ,
Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?, Clinical Colorectal Cancer, vol.10, issue.2, pp.73-80, 2011. ,
DOI : 10.1016/j.clcc.2011.03.001
Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin, Journal of Clinical Oncology, vol.31, issue.36, pp.4512-4519, 2013. ,
DOI : 10.1200/JCO.2012.47.3116
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer, New England Journal of Medicine, vol.374, issue.3, pp.211-222, 2016. ,
DOI : 10.1056/NEJMoa1506597